CuraGen Corporation - SWOT Analysis

CuraGen Corporation - SWOT Analysis
  • Report price : $ 125
  • Publication date : March 2008
  • Length : 37 pages

Get this Report Now !

CuraGen Corporation - SWOT Analysis

Datamonitor's CuraGen Corporation - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

CuraGen is a biopharmaceutical company that develops a pipeline of protein, antibody, and small molecule therapeutic products. The company is engaged in the development of pharmaceutical products in the areas of oncology, inflammatory disease and diabetes. CuraGen is headquartered in Branford, Connecticut and employed 255 people as of December 2006. The company recorded revenues of $40 million during the fiscal year ended December 2006, an increase of 68% over 2005. The operating loss of the company was $59 million during 2006 compared to $74 million in 2005. The net loss in fiscal year 2006 was $60 million compared to $73 million in 2005.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available

RELATED REPORTS

Global Dialysis Market: Hemodialysis Continues to be the Preferred Treatment Method

Global Dialysis Market: Hemodialysis Continues to be the Preferred Treatment Method

  • $ 850
  • January 2008
  • 30 pages

Public healthcare programs reimburse costs for majority of dialysis treatments in the United States and in Western Europe. The governments of these regions are considering proposals for controlling costs by altering the public-sponsored healthcare programs. This move is likely to change the profita ...

Industries : Medical Devices, Pathology, Healthcare | Countries : USA

The World Hypertension Market 2007-2023

The World Hypertension Market 2007-2023

  • $ 3 621
  • September 2007
  • 200 pages

The market for hypertensives - led by the angiotensin II antagonists - is one of the largest and most profitable in the global pharmaceutical market, with total anti-hypertensive sales of $36600m in 2006. Hypertension, or high blood pressure, is a worldwide epidemic: by 2025 visiongain predict that ...

Industries : Pathology | Countries : USA, Japan

The World Diabetes Market, 2006-2025

The World Diabetes Market, 2006-2025

  • $ 3 621
  • October 2007
  • 200 pages

Diabetes affects approximately 246 million people worldwide and this number is increasing. The IDF predict 380 million diabetics by 2025. The Global Diabetes drug treatment market was valued at over $21 billion in 2006 and the market is still expanding rapidly due to the high prevalence of diabetes ...

Industries : Pathology | Countries : USA, Japan, Denmark

Congestive Heart Failure: Major World Markets, Volume II: Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)

Congestive Heart Failure: Major World Markets, Volume II: Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)

  • $ 3 495
  • February 2008
  • 200 pages

Congestive heart failure, a condition caused by a malfunctioning heart that is unable to pump enough blood and oxygen to meet the body’s needs, is an increasingly important cause of cardiovascular morbidity and mortality. With improvements in the care of other cardiac conditions, more patients hav ...

Industries : Pathology | Countries : USA, Japan

World Market for Prescription Cardiovascular Drugs, 2nd Edition, The

World Market for Prescription Cardiovascular Drugs, 2nd Edition, The

  • $ 3 995
  • December 2007
  • 265 pages

As one of the most competitive pharmaceutical markets, keeping track of the cardiovascular drug market can be a difficult undertaking. The range of therapeutic options available to physicians has expanded significantly in the past few years, and will continue to increase with a robust pipeline. Kal ...

Industries : Pathology | Countries : USA

Amylin Pharmaceuticals Inc - SWOT Analysis

Amylin Pharmaceuticals Inc - SWOT Analysis

  • $ 125
  • March 2008
  • 37 pages

Datamonitor's Amylin Pharmaceuticals Inc - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and st ...

Industries : Pathology | Countries : USA, Germany

AstraZeneca PLC - SWOT Analysis

AstraZeneca PLC - SWOT Analysis

  • $ 125
  • March 2008
  • 45 pages

Datamonitor's AstraZeneca PLC - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Ast ...

Industries : Pathology | Countries : USA, Sweden, United Kingdom

Eli Lilly and Company - SWOT Analysis

Eli Lilly and Company - SWOT Analysis

  • $ 125
  • March 2008
  • 54 pages

Datamonitor's Eli Lilly and Company - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy ...

Industries : Pathology | Countries : USA

Vaccines

Vaccines

  • $ 750
  • March 2008
  • 143 pages

Vaccine manufacturers from all over the world have been involved in a stalemate with governments regarding supply and demand. While governments are reluctant to ensure steady demand for vaccines unless the manufacturers can prove their ability to increase their supply, the latter are apprehensive a ...

Industries : Pathology | Countries : USA, India

Personal Protective Equipment : Spain

Personal Protective Equipment : Spain

  • $ 2 181
  • February 2008
  • 182 pages

In this report, now available in English for the first time, MSI analyses the Spanish personal protective equipment market for a five-year review period (2003-2007) and a five year forecast period up until 2012. Our regular clients asked us to produce an English version of our detailed market study, ...

Industries : Clothing Accessories, Security Services, Pathology, Clothing and Textile | Countries : USA, Spain, United Kingdom

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.